Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Statins and the risk of rhabdomyolysis.

× No keyword cloud information.

13 in total

1. Statin-fibrate combinations in patients with combined hyperlipedemia.

Authors: V G Athyros; A A Papageorgiou; A G Kontopoulos
Journal: Atherosclerosis Date: 2001-03 Impact factor: 5.162

2. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors:
Journal: JAMA Date: 2001-05-16 Impact factor: 56.272

Review 3. Physicians' interpretation of "class effects": a need for thoughtful re-evaluation.

Authors: Harold L Kennedy; Robert S Rosenson
Journal: J Am Coll Cardiol Date: 2002-07-03 Impact factor: 24.094

4. Differential sensitivity of C2-C12 striated muscle cells to lovastatin and pravastatin.

Authors: A P Gadbut; A P Caruso; J B Galper
Journal: J Mol Cell Cardiol Date: 1995-10 Impact factor: 5.000

5. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors: Earl S Ford; Wayne H Giles; William H Dietz
Journal: JAMA Date: 2002-01-16 Impact factor: 56.272

6. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

Authors:
Journal: N Engl J Med Date: 1998-11-05 Impact factor: 91.245

7. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors: J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal: JAMA Date: 1998-05-27 Impact factor: 56.272

8. Long-term safety of pravastatin-gemfibrozil therapy in mixed hyperlipidemia.

Authors: E A Iliadis; R S Rosenson
Journal: Clin Cardiol Date: 1999-01 Impact factor: 2.882

9. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors: J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal: N Engl J Med Date: 1995-11-16 Impact factor: 91.245

10. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)

Authors:
Journal: Lancet Date: 1995-05-20 Impact factor: 79.321

1 in total

1. Rosuvastatin Pharmacokinetics in Asian and White Subjects Wild Type for Both OATP1B1 and BCRP Under Control and Inhibited Conditions.

Authors: Hsin-Fang Wu; Nadya Hristeva; Jae Chang; Xiaorong Liang; Ruina Li; Lynda Frassetto; Leslie Z Benet
Journal: J Pharm Sci Date: 2017-04-03 Impact factor: 3.534

1 in total